Page last updated: 2024-11-07

prednisone and Cystadenocarcinoma, Papillary

prednisone has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ollivier, Y1
Andrès, C1
Laplaud, AL1
Sevin, E1
Letellier, P1

Other Studies

1 other study available for prednisone and Cystadenocarcinoma, Papillary

ArticleYear
[Palmar fasciitis after carboplatin administration for an ovarian adenocarcinoma].
    La Revue de medecine interne, 2006, Volume: 27, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Cystadenocarcinoma, Papillary; F

2006